Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Gift Director gave 850 shares (gift)
  2. 4 Open-market sale EVP, Research and Development sold 1,000 shares at $350.00 ($350,000)
  3. 4 Shares withheld for taxes EVP, Human Resources gave up 163 shares (to pay taxes)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 880 shares (grant or award)
  7. 4 Grant or award Director acquired 880 shares (grant or award)
  8. 4 Grant or award Director acquired 880 shares (grant or award)
  9. 4 Grant or award Director acquired 880 shares (grant or award)
  10. 4 Grant or award Director acquired 880 shares (grant or award)
  11. 4 Grant or award Director acquired 880 shares (grant or award)
  12. 4 Grant or award Director acquired 1,450 shares (grant or award)
  13. 4 Grant or award Director acquired 880 shares (grant or award)
  14. 4 Grant or award Director acquired 880 shares (grant or award)
  15. 4 Grant or award Director acquired 880 shares (grant or award)
  16. 4 Shares withheld for taxes EVP, Research and Development gave up 1,076 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 750 shares (to pay taxes)
  18. 4 Open-market buy Director bought 48,000 shares at $269.91 ($12,955,680)
  19. 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 642 shares (to pay taxes)
  20. 4 Derivatives Options or other derivatives

Page 20 of 86 · 1,714 filings